India, Oct. 13 -- Johnson & Johnson (JNJ) is down 5.12 percent, losing $13.49 to $250.24 on Monday. The decline follows the healthcare giant's third-quarter results, which showed net earnings plunging 96 percent to $210 million, or $0.09 per share, from $5.15 billion, or $2.12 per share, a year earlier, mainly due to a one-time special charge related to the proposed talc litigation resolution.
Johnson & Johnson is currently trading at $250.24, down from the previous close of $263.73 after opening at $254.56 on the New York Stock Exchange. The stock has traded between $249.83 and $256.18 during the session. Trading volume stands at 2.30 million shares, compared with an average volume of 7.01 million shares.
googletag.cmd.push(function() { ...